Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Stankiewicz

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2016
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarateMoogeh Baharnoori, Jennifer Lyons, Akram Dastagir, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 17, 2021
Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosisVanessa F Moreira Ferreira, Yanqing Liu, Brian C Healy, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Experience with long-term rituximab use in a multiple sclerosis clinicMegan E Barra, Dhruv Soni, Khac Huy Vo, et al.
Multiple Sclerosis International|December 31, 2020
Teriflunomide Safety and Efficacy in Advanced Progressive Multiple SclerosisVanessa F Moreira Ferreira, Danielle Caefer, Natalie Erlich-Malona, et al.
The International Journal of Neuroscience|May 5, 2016
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosisFariha Khalid, Shahamat Tauhid, Alicia S Chua, et al.
The International Journal of Neuroscience|January 20, 2017
Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosisGloria Kim, Renxin Chu, Fawad Yousuf, et al.
Neurology. Clinical Practice|January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MSMaria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Journal of Neurology|June 5, 2020
COVID-19 in teriflunomide-treated patients with multiple sclerosisAmir Hadi Maghzi, Maria K Houtchens, Paolo Preziosa, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosisJames M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Neuroreport|August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2016
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarateMoogeh Baharnoori, Jennifer Lyons, Akram Dastagir, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 17, 2021
Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosisVanessa F Moreira Ferreira, Yanqing Liu, Brian C Healy, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Experience with long-term rituximab use in a multiple sclerosis clinicMegan E Barra, Dhruv Soni, Khac Huy Vo, et al.
Multiple Sclerosis International|December 31, 2020
Teriflunomide Safety and Efficacy in Advanced Progressive Multiple SclerosisVanessa F Moreira Ferreira, Danielle Caefer, Natalie Erlich-Malona, et al.
The International Journal of Neuroscience|May 5, 2016
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosisFariha Khalid, Shahamat Tauhid, Alicia S Chua, et al.
The International Journal of Neuroscience|January 20, 2017
Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosisGloria Kim, Renxin Chu, Fawad Yousuf, et al.
Neurology. Clinical Practice|January 15, 2025
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MSMaria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, et al.
Journal of Neurology|June 5, 2020
COVID-19 in teriflunomide-treated patients with multiple sclerosisAmir Hadi Maghzi, Maria K Houtchens, Paolo Preziosa, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosisJames M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Neuroreport|August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Pageof 3